When There Is No Vaccine

Passive immunization is the answer.

Written byJack Woodall
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

In 1942, long before the vaccine was available, I contracted measles, went into a coma, but recovered. My younger brother and sister received transfusions of immune serum from our mother, who had had measles as a child, and were protected. My siblings were not the only ones to benefit from serum treatment: In 1970, two people working on Lassa fever at a university research lab caught the illness, and one died. The other was diagnosed in time, received immune serum from a Lassa survivor, and recovered.

Vaccines have saved countless lives. But there are still diseases that cause large numbers of cases and deaths, such as dengue and malaria, for which vaccines have been sought for decades but always seem to be five years in the future. Other important diseases like Ebola and Lassa fevers are crying out for vaccines, which are under development but still predicted to take years ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies